FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2079407624> ?p ?o ?g. }

• W2079407624 endingPage "41" @default.
• W2079407624 startingPage "41" @default.
• W2079407624 abstract "Background/Aims This study investigated the antiviral effects of tenofovir disoproxil fumarate (TDF) monotherapy in nucleos(t)ide analogue (NA)-naive and NA-experienced chronic hepatitis B (CHB) patients. Methods CHB patients treated with TDF monotherapy (300 mg/day) for ≥12 weeks between December 2012 and July 2014 at a single center were retrospectively enrolled. Clinical, biochemical, and virological parameters were assessed every 12 weeks. Results In total, 136 patients (median age 49 years, 96 males, 94 HBeAg positive, and 51 with liver cirrhosis) were included. Sixty-two patients were nucleos(t)ide (NA)-naïve, and 74 patients had prior NA therapy (NA-exp group), and 31 patients in the NA-exp group had lamivudine (LAM)-resistance (LAM-R group). The baseline serum hepatitis B virus (HBV) DNA level was 4.9±2.3 log IU/mL (mean±SD), and was higher in the NA-naïve group than in the NA-exp and LAM-R groups (5.9±2.0 log IU/mL vs 3.9±2.0 log IU/mL vs 4.2±1.7 log IU/mL, P<0.01). The complete virological response (CVR) rate at week 48 in the NA-naïve group (71.4%) did not differ significantly from those in the NA-exp (71.3%) and LAM-R (66.1%) groups. In multivariate analysis, baseline serum HBV DNA was the only predictive factor for a CVR at week 48 (hazard ratio, 0.809; 95% confidence interval, 0.729-0.898), while the CVR rate did not differ with the NA experience. Conclusions TDF monotherapy was effective for CHB treatment irrespective of prior NA treatment or LAM resistance. Baseline serum HBV DNA was the independent predictive factor for a CVR. Keywords: Chronic Hepatitis B; Tenofovir; Nucleos(t)ide analogue-experienced; Lamivudine-resistant" @default.
• W2079407624 created "2016-06-24" @default.
• W2079407624 creator A5005757596 @default.
• W2079407624 creator A5008014896 @default.
• W2079407624 creator A5014807072 @default.
• W2079407624 creator A5022961179 @default.
• W2079407624 creator A5024081761 @default.
• W2079407624 creator A5042973847 @default.
• W2079407624 creator A5044632896 @default.
• W2079407624 creator A5057565007 @default.
• W2079407624 creator A5061984381 @default.
• W2079407624 creator A5062787269 @default.
• W2079407624 creator A5080466465 @default.
• W2079407624 creator A5088839809 @default.
• W2079407624 date "2015-01-01" @default.
• W2079407624 modified "2023-09-24" @default.
• W2079407624 title "Tenofovir disoproxil fumarate monotherapy for nucleos(t)ide analogue-naïve and nucleos(t)ide analogue-experienced chronic hepatitis B patients" @default.
• W2079407624 cites W1643958559 @default.
• W2079407624 cites W1964448944 @default.
• W2079407624 cites W1973933851 @default.
• W2079407624 cites W1991359390 @default.
• W2079407624 cites W1998974659 @default.
• W2079407624 cites W2004100607 @default.
• W2079407624 cites W2031360806 @default.
• W2079407624 cites W2048759891 @default.
• W2079407624 cites W2059560167 @default.
• W2079407624 cites W2075704407 @default.
• W2079407624 cites W2083539150 @default.
• W2079407624 cites W2090738619 @default.
• W2079407624 cites W2104389844 @default.
• W2079407624 cites W2125211506 @default.
• W2079407624 cites W2145349124 @default.
• W2079407624 cites W2147133758 @default.
• W2079407624 cites W2162520409 @default.
• W2079407624 cites W2163577777 @default.
• W2079407624 cites W2167744756 @default.
• W2079407624 cites W4211026375 @default.
• W2079407624 cites W4211077792 @default.
• W2079407624 doi "https://doi.org/10.3350/cmh.2015.21.1.41" @default.
• W2079407624 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4379196" @default.
• W2079407624 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25834801" @default.
• W2079407624 hasPublicationYear "2015" @default.
• W2079407624 type Work @default.
• W2079407624 sameAs 2079407624 @default.
• W2079407624 citedByCount "13" @default.
• W2079407624 countsByYear W20794076242015 @default.
• W2079407624 countsByYear W20794076242016 @default.
• W2079407624 countsByYear W20794076242017 @default.
• W2079407624 countsByYear W20794076242018 @default.
• W2079407624 countsByYear W20794076242022 @default.
• W2079407624 countsByYear W20794076242023 @default.
• W2079407624 crossrefType "journal-article" @default.
• W2079407624 hasAuthorship W2079407624A5005757596 @default.
• W2079407624 hasAuthorship W2079407624A5008014896 @default.
• W2079407624 hasAuthorship W2079407624A5014807072 @default.
• W2079407624 hasAuthorship W2079407624A5022961179 @default.
• W2079407624 hasAuthorship W2079407624A5024081761 @default.
• W2079407624 hasAuthorship W2079407624A5042973847 @default.
• W2079407624 hasAuthorship W2079407624A5044632896 @default.
• W2079407624 hasAuthorship W2079407624A5057565007 @default.
• W2079407624 hasAuthorship W2079407624A5061984381 @default.
• W2079407624 hasAuthorship W2079407624A5062787269 @default.
• W2079407624 hasAuthorship W2079407624A5080466465 @default.
• W2079407624 hasAuthorship W2079407624A5088839809 @default.
• W2079407624 hasBestOaLocation W20794076241 @default.
• W2079407624 hasConcept C126322002 @default.
• W2079407624 hasConcept C203014093 @default.
• W2079407624 hasConcept C207103383 @default.
• W2079407624 hasConcept C2522874641 @default.
• W2079407624 hasConcept C2775940106 @default.
• W2079407624 hasConcept C2777214474 @default.
• W2079407624 hasConcept C2777382497 @default.
• W2079407624 hasConcept C2777410769 @default.
• W2079407624 hasConcept C2777869810 @default.
• W2079407624 hasConcept C2779344132 @default.
• W2079407624 hasConcept C2780593183 @default.
• W2079407624 hasConcept C3013748606 @default.
• W2079407624 hasConcept C44249647 @default.
• W2079407624 hasConcept C71924100 @default.
• W2079407624 hasConcept C90924648 @default.
• W2079407624 hasConceptScore W2079407624C126322002 @default.
• W2079407624 hasConceptScore W2079407624C203014093 @default.
• W2079407624 hasConceptScore W2079407624C207103383 @default.
• W2079407624 hasConceptScore W2079407624C2522874641 @default.
• W2079407624 hasConceptScore W2079407624C2775940106 @default.
• W2079407624 hasConceptScore W2079407624C2777214474 @default.
• W2079407624 hasConceptScore W2079407624C2777382497 @default.
• W2079407624 hasConceptScore W2079407624C2777410769 @default.
• W2079407624 hasConceptScore W2079407624C2777869810 @default.
• W2079407624 hasConceptScore W2079407624C2779344132 @default.
• W2079407624 hasConceptScore W2079407624C2780593183 @default.
• W2079407624 hasConceptScore W2079407624C3013748606 @default.
• W2079407624 hasConceptScore W2079407624C44249647 @default.
• W2079407624 hasConceptScore W2079407624C71924100 @default.
• W2079407624 hasConceptScore W2079407624C90924648 @default.
• W2079407624 hasIssue "1" @default.
• W2079407624 hasLocation W20794076241 @default.
• W2079407624 hasLocation W20794076242 @default.

• next